Results
|
1701.
|
|
|
1702.
|
Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer. [electronic resource] by
- Li, Xiaoxian
- Wetherilt, Ceyda Sonmez
- Krishnamurti, Uma
- Yang, Jing
- Ma, Yamin
- Styblo, Toncred M
- Meisel, Jane L
- Peng, Limin
- Siddiqui, Momin T
- Cohen, Cynthia
- Aneja, Ritu
Producer: 20170227
In:
American journal of clinical pathology vol. 146
Availability: No items available.
|
|
1703.
|
|
|
1704.
|
|
|
1705.
|
Relationship of tumor PD-L1 expression with EGFR wild-type status and poor prognosis in lung adenocarcinoma. [electronic resource] by
- Inamura, Kentaro
- Yokouchi, Yusuke
- Sakakibara, Rie
- Kobayashi, Maki
- Subat, Sophia
- Ninomiya, Hironori
- Nagano, Hiroko
- Nomura, Kimie
- Okumura, Sakae
- Ishikawa, Yuichi
Producer: 20170315
In:
Japanese journal of clinical oncology vol. 46
Availability: No items available.
|
|
1706.
|
|
|
1707.
|
|
|
1708.
|
|
|
1709.
|
Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification. [electronic resource] by
- Chen, Meixuan
- Andreozzi, Mariacarla
- Pockaj, Barbara
- Barrett, Michael T
- Ocal, Idris Tolgay
- McCullough, Ann E
- Linnaus, Maria E
- Chang, James M
- Yearley, Jennifer H
- Annamalai, Lakshmanan
- Anderson, Karen S
Producer: 20180629
In:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 30
Availability: No items available.
|
|
1710.
|
|
|
1711.
|
|
|
1712.
|
|
|
1713.
|
|
|
1714.
|
|
|
1715.
|
|
|
1716.
|
HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer. [electronic resource] by
- Fukumoto, Takeshi
- Fatkhutdinov, Nail
- Zundell, Joseph A
- Tcyganov, Evgenii N
- Nacarelli, Timothy
- Karakashev, Sergey
- Wu, Shuai
- Liu, Qin
- Gabrilovich, Dmitry I
- Zhang, Rugang
Producer: 20200514
In:
Cancer research vol. 79
Availability: No items available.
|
|
1717.
|
Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells. [electronic resource] by
- Yang, Yuanyuan
- Zhang, Xiaolong
- Lin, Fangzhen
- Xiong, Mengshang
- Fan, Dongmei
- Yuan, Xiangfei
- Lu, Yang
- Song, Yuewen
- Zhang, Yizi
- Hao, Mu
- Ye, Zhou
- Zhang, Yanjun
- Wang, Jianxiang
- Xiong, Dongsheng
Producer: 20200515
In:
Journal of hematology & oncology vol. 12
Availability: No items available.
|
|
1718.
|
|
|
1719.
|
|
|
1720.
|
|